1. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma
    Li-Li Mei et al, 2017, IJMS CrossRef
  2. Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy
    Mohammad Shayestehpour et al, 2017, Virus Research CrossRef
  3. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
    Masoumeh Adhami et al, 2018, Breast Cancer CrossRef
  4. Mixomics analysis of Breast Cancer: Long non-coding RNA linc01561 acts as ceRNA involved in the progression of breast cancer
    Rui Jiang et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  5. Suppressive and Hypermethylated MicroRNAs in the Pathogenesis of Breast Cancer
    V. I. Loginov et al, 2018, Russ J Genet CrossRef
  6. MiR-145-targeted HBXIP modulates human breast cancer cell proliferation
    Yang Jiang et al, 2018, Thorac Cancer CrossRef
  7. miR-125 regulates PI3K/Akt/mTOR signaling pathway in rheumatoid arthritis rats via PARP2
    Kai Liu et al, 2019, Biosci. Rep. CrossRef
  8. The role of inflammation and its related microRNAs in breast cancer: A narrative review
    Alireza Bahiraee et al, 2019, J Cell Physiol CrossRef
  9. Differential clinical significance of COL 5A1 and COL 5A2 in tongue squamous cell carcinoma
    Hung‐Chih Chen et al, 2019, J Oral Pathol Med CrossRef
  10. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1
    Qiu Du et al, 2019 CrossRef
  11. The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines
    Gizem Örs Kumoğlu et al, 2019, Gene CrossRef
  12. miR‐145 inhibits glutamine metabolism through c‐myc/GLS1 pathways in ovarian cancer cells
    Jie Li et al, 2019, Cell Biol Int CrossRef
  13. Dynamic Interplay between miRNAs and the Extracellular Matrix Influences the Tumor Microenvironment
    Zoi Piperigkou et al, 2019, Trends in Biochemical Sciences CrossRef
  14. miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.
    Evita Maria Lindholm et al, 2019, Mol Oncol CrossRef
  15. Designing Distributed Cell Classifier Circuits Using a Genetic Algorithm
    Melania Nowicka et al, 2019 CrossRef
  16. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway
    Ying Niu et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
  17. MiR‐145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF‐κB pathway regulation
    Gengyu Chen et al, 2020, J Cell Biochem CrossRef
  18. Activation of TGF-β1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression
    Xuhui Yang et al, 2020, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  19. MicroRNA-145 is involved in endothelial cell dysfunction and acts as a promising biomarker of acute coronary syndrome
    Shanshan Wu et al, 2020, Eur J Med Res CrossRef
  20. Functional implications of miR-145/RCAN3 axis in the progression of cervical cancer
    Xian-Yu Zhang et al, 2020, Reproductive Biology CrossRef
  21. MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD4
    Jie Zhou et al, 2020, J Ovarian Res CrossRef
  22. Overexpression of microRNA-145 inhibits tumorigenesis through autophagy in chemotherapy and radiation resistant neuroblastoma cells
    Kwang Woon Kim et al, 2020, Oncoscience CrossRef
  23. miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1
    Kun Liu et al, 2018, Int J Oncol CrossRef
  24. MicroRNA-671-3p inhibits the development of breast cancer: A study based on in vitro experiments, in-house quantitative polymerase chain reaction and bioinformatics analysis.
    Dan-Dan Xiong et al, 0 CrossRef
  25. Silencing long intergenic non‑coding RNA 00707 enhances cisplatin sensitivity in cisplatin‑resistant non‑small‑cell lung cancer cells by sponging miR‑145
    Hongde Zhang et al, 2019, Oncol Lett CrossRef
  26. Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
    Jun Sheng Wong et al, 2020, ncRNA CrossRef

  27. CircEPSTI1 Promotes the Progression of Non-Small Cell Lung Cancer Through miR-145/HMGB3 Axis


    Yuanyuan Xie et al, 2020, CMAR CrossRef
  28. Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients
    Alaa M Ibrahim et al, 2020, Tumour Biol. CrossRef
  29. NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells
    Maritza P. Garrido et al, 2020, IJMS CrossRef
  30. Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis
    Huan Lu et al, 2021, J Ovarian Res CrossRef
  31. miRNAs: Critical mediators of breast cancer metastatic programming.
    Madhumathy G Nair et al, 2021, Exp Cell Res CrossRef
  32. Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis
    Anna Stejskalová et al, 2021, Sci Rep CrossRef
  33. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer
    Maha M. Itani et al, 2021, IJMS CrossRef
  34. Perception of breast cancer risk factors: Dysregulation of TGF-β/miRNA axis in Pakistani females
    Fayyaz Ahmed et al, 2021, PLoS ONE CrossRef
  35. si‑MALAT1 attenuates thymic cancer cell proliferation and promotes apoptosis via the miR‑145‑5p/HMGA2 pathway
    Sheng Tan et al, 2021, Oncol Lett CrossRef
  36. Molecular mechanism of miR‐153 inhibiting migration, invasion and epithelial‐mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF‐β) signaling pathway
    Jingwei Wang et al, 2019, J Cell Biochem CrossRef
  37. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review.
    Sergiusz Łukasiewicz et al, 2021, Cancers (Basel) CrossRef
  38. The role of noncoding RNAs in pituitary adenoma
    Farbod Bahreini et al, 2021, Epigenomics CrossRef
  39. Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature
    Chrystel Isca et al, 2021, Cancers CrossRef
  40. MicroRNA-145 Involves in the Pathogenesis of Renal Vascular Lesions and May Become a Potential Therapeutic Target in Patients with Juvenile Lupus Nephritis
    Zhaomin Cai et al, 2019, Kidney Blood Press Res CrossRef
  41. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer
    Juanni liu et al, 2021, Bioengineered CrossRef
  42. CircRNA_0044556 diminishes the sensitivity of triple‑negative breast cancer cells to adriamycin by sponging miR‑145 and regulating NRAS
    Jingjing Chen et al, 2021, Mol Med Rep CrossRef
  43. Organelles coordinate milk production and secretion during lactation: Insights into mammary pathologies
    Wenting Dai et al, 2022, Progress in Lipid Research CrossRef
  44. Overexpression of microRNA-145 enhanced docetaxel sensitivity in breast cancer cells via inactivation of protein kinase B gamma-mediated phosphoinositide 3-kinase -protein kinase B pathway
    Ying Zhou et al, 2022, Bioengineered CrossRef
  45. Mesenchymal stem cells and cancer‐associated fibroblasts as a therapeutic strategy for breast cancer
    Francisco Raúl Borzone et al, 2022, British J Pharmacology CrossRef
  46. Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
    Gabriela Green-Tripp et al, 2022, Front. Mol. Biosci. CrossRef
  47. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo.
    Jing Zhao et al, 2020, Bioengineered CrossRef
  48. The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells via the upregulation of miR-31
    Xiaoxia Tian et al, 2022, Front. Oncol. CrossRef
  49. The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women
    Safinaz E. El-Toukhy et al, 2022, J Cancer Res Clin Oncol CrossRef
  50. Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
    Matthew G Davey et al, 2023 CrossRef
  51. Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
    Sara Hajibabaei et al, 2023, Sci Rep CrossRef
  52. miR‐145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on MYC
    Chenchen Hu et al, 2023, The FASEB Journal CrossRef
  53. Adaptive Sparse Multi-Block PLS Discriminant Analysis: An Integrative Method for Identifying Key Biomarkers from Multi-Omics Data
    Runzhi Zhang et al, 2023, Genes CrossRef
  54. Genome-wide profiling of miRNA-gene regulatory networks in mouse postnatal heart development—implications for cardiac regeneration
    Umesh Chaudhari et al, 2023, Front. Cardiovasc. Med. CrossRef
  55. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells
    Ali Tafti et al, 2023, Molecular Carcinogenesis CrossRef
  56. MIR-145's Regulatory Role in Breast Cancer Progression
    Boran Can DİNÇER, 2023 CrossRef
  57. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice
    Laura Lopez-Gonzalez et al, 2024, Medicina CrossRef
  58. Inhibition of breast cancer cell growth and migration through siRNA-mediated modulation of circ_0009910/miR-145-5p/MUC1 axis
    Maryam Abtin et al, 2024, Non-coding RNA Research CrossRef
  59. Hypoxia-driven hybrid phenotypes in Ewing sarcoma: Insights from computational epithelial-mesenchymal transition modeling
    Daner A. Silveira et al, 2024, Journal of Computational Science CrossRef
  60. Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR‐145 into the Breast Cancer Cell Line and Its Effect on Metastasis
    Mohsen Sheykhhasan et al, 2021, BioMed Research International CrossRef
  61. Berberine Inhibits Breast Cancer Stem Cells Development and Decreases Inflammation: Involvement of miRNAs and Interleukin-6
    Nour Ibrahim et al, 2024, Current Developments in Nutrition CrossRef